Navigation Links
Pressure BioSciences' Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
Date:7/18/2012

ng the Company's PCT product line because scientists may not perceive the advantages of PCT over other sample preparation methods; that other researchers may not be able to replicate the data reported in the studies mentioned; and if actual operating costs are higher than anticipated, or revenues from product sales are less than anticipated, the Company may need additional capital beyond August 2012. Further, given the uncertainty in the capital markets and the current status of the Company's product development and commercialization activities, there can be no assurance that the Company will secure the additional capital necessary to fund its operations beyond August 2012 on acceptable terms, if at all.  Additional risks and uncertainties that could cause actual results to differ materially from those indicated by these forward-looking statements are discussed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2011, and other reports filed by the Company from time to time with the SEC. The Company undertakes no obligation to update any of the information included in this release, except as otherwise required by law.

PBI filed a registration statement (including a prospectus) with the SEC for an offering to which this communication may relate. Before you invest, you should read the prospectus in that registration statement for the offering and other documents PBI has filed with the SEC for more complete information about PBI and the offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, PBI can arrange to send you the prospectus, when available, upon request.

For more information about PBI and this press release, please click on the following link:  http://www.pressurebiosciences.com

Investor Contacts:

'/>"/>

SOURCE Pressure BioSciences, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Failure to Take Medicine Linked to Unnecessary Hospital Visits, Especially for Medicare Patients Taking High Blood Pressure or High Cholesterol Medications
3. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
4. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
5. Negative Pressure Wound Therapy (NPWT) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2018
6. Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
8. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
9. Neurocrine Biosciences Reports First Quarter 2012 Results
10. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
11. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014  PANTHERx Specialty ... Specialty Pharmacy Accreditation from URAC, a ... that establishes quality standards for the health care ... The URAC accreditation process demonstrates ... a framework to improve business processes through benchmarking ...
(Date:9/2/2014)... Calif. , Sept. 2, 2014  Based ... tumor treatment device market, Frost & Sullivan recognizes ... Frost & Sullivan Award for Technology Innovation Leadership. ... breast fibroadenoma and malignant tumors with its proprietary ... tool is a reliable, accurate, and easy-to-control ultrasound-guided ...
(Date:9/2/2014)... Mast Therapeutics, Inc . (NYSE MKT: MSTX) today announced that the ... at the Rodman and Renshaw 16 th Annual Global Investment ... in the Holmes II Salon at The New York Palace Hotel ... parties can access a live audio webcast and slide presentation on ... presentation will be available on the web site for 30 days. ...
Breaking Medicine Technology:PANTHERx Specialty Pharmacy Applying for URAC Specialty Pharmacy Accreditation 2Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 2Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 3Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 4Novian Health Wins Acclaim from Frost & Sullivan for Novilase Interstitial Laser Ablation Therapy for Early-Stage Malignant Breast Tumors 5Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 2Mast Therapeutics To Present At The Rodman And Renshaw 16th Annual Global Investment Conference On September 9th 3
(Date:9/2/2014)... in Spanish . ... an experiment conducted on rats, that hyperproteic diets could be ... groups with bone disease problems, such as the elderly or ... proteinin the case of the present study, soy proteinis preferable ... increased the level of calcium in bones by as much ...
(Date:9/2/2014)... (PRWEB) September 02, 2014 According ... http://www.idataresearch.com ), the leading global authority in medical ... market is expected to grow to over ... by an increase in the number of procedures ... kidney stones. This market includes TURP devices, laser ...
(Date:9/2/2014)... Splashtop Inc. , the worldwide leader ... NTT DoCoMo to deliver Splashtop Business Lite for ... is included in NTT DoCoMo’s “Business Plus” program. , ... empower users to remote access their corporate computers from ... million users worldwide. Splashtop delivers the best in ...
(Date:9/2/2014)... Medical Goods manufacture ThermoTek , announced today a ... Inc. to help customers acquire capital goods faster and ... finance shopping platform has enabled businesses to quickly and ... business. , Said LeaseQ Vice President Cory Damm, ... to provide customers faster access to capital and allow ...
(Date:9/2/2014)... September 02, 2014 Based on ... used during hysterectomy, kidney and spleen surgeries, have ... cells and harm patients. , An article ... Michael A. Seidman, Titilope Oduyebo and Bradley J. ... Mesenchymal Neoplasms" published on Nov 26, 2012 defines ...
Breaking Medicine News(10 mins):Health News:Study conducted on rats suggests that hyperproteic diets can be beneficial for bones 2Health News:European Urological Device Market Is Expected to Grow to over €2 billion by 2020: Led by Coloplast, Wellspect HealthCare, Teleflex, C. R. Bard and Olympus 2Health News:European Urological Device Market Is Expected to Grow to over €2 billion by 2020: Led by Coloplast, Wellspect HealthCare, Teleflex, C. R. Bard and Olympus 3Health News:Splashtop and NTT DoCoMo Partner to Deliver “Splashtop Business Lite” Secure Remote Access Solution to Business Customers 2Health News:Medical Technology Manufacturer ThermoTek Announces New Partnership with LeaseQ.com to Help More Customers Acquire Equipment Faster and Cheaper 2Health News:New York Law Firm Discusses Allegedly Dangerous Surgical Morcellator Devices And Cancer Risk 2Health News:New York Law Firm Discusses Allegedly Dangerous Surgical Morcellator Devices And Cancer Risk 3
... HealthDay Reporter , TUESDAY, Aug. 24 (HealthDay News) -- ... by a U.S. judge to halt any expansion ... temporary injunction, which basically blindsided the scientific community, effectively ... days. That was when then-President Bush ordered that federal ...
... people lose weight and body fat when they exercise and eat ... (MR) spectroscopy can provide the answer and help predict who ... online and will appear in the November issue of the journal ... the same and have the same body mass index (BMI), but ...
... HealthDay Reporter , TUESDAY, Aug. 24 (HealthDay News) -- ... a day boost a woman,s odds of premature delivery? ... The researchers looked at the soft drink habits of ... from 1996 to 2002. The investigators found a link ...
... 2010 The Joint Commission has certified UT Southwestern ... Center, a distinction for hospitals fostering specialized stroke care ... imaging specialists, nurses and technicians have ready access to ... or after a stroke. Each year about 700,000 people ...
... breast imaging exams may increase a woman,s risk of ... online and in the October issue of Radiology ... are very low. "A single breast-specific gamma imaging ... lifetime risk of inducing fatal cancer greater than or ...
... 2010) While success is surely sweeter than failure, it ... fail spectacularly often flourish more in the long run, ... of management at the University of Colorado Denver Business School. ... Journal , focused on companies and organizations that launch satellites, ...
Cached Medicine News:Health News:Scientists Dismayed by Stem Cell Research Ruling 2Health News:Scientists Dismayed by Stem Cell Research Ruling 3Health News:Fat distribution plays a role in weight loss success in patients at risk of diabetes 2Health News:Study Suggests Link Between Diet Sodas, Preterm Delivery 2Health News:Study Suggests Link Between Diet Sodas, Preterm Delivery 3Health News:UT Southwestern University Hospital -- St. Paul recognized as Primary Stroke Center 2Health News:UT Southwestern University Hospital -- St. Paul recognized as Primary Stroke Center 3Health News:New nuclear breast imaging technologies associated with higher cancer risks 2Health News:New nuclear breast imaging technologies associated with higher cancer risks 3Health News:University of Colorado Denver Business School study shows failure better teacher than success 2
Rapid reagent impregnated disk test for presumptive identification of Candida albicans....
... Electronic Medical Records for small and large ... from check-in to check-out. Review the complete ... medications, to allergies, labs and charts all ... your patient records immediately. Communicate electronically with ...
... Written specifically for urologists by ... utilizes touch screen technology to ... eliminate the use of a ... makes using an EMR faster ...
... a new generation of advanced Electronic Medical ... the largest, numerically codified medical vocabularies in ... data elements embedded in MedcomSoft Record, healthcare ... an easy and intuitive point and click ...
Medicine Products: